|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-9-14
|
|
pubmed:abstractText |
To prospectively follow the concentrations of plasma adiponectin (p-adiponectin) and serum advanced glycation end-products (s-AGE) in relation to plasma lipids and retinopathy over 3 years in type 2 diabetic patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
151
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
361-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15362966-Adiponectin,
pubmed-meshheading:15362966-Aged,
pubmed-meshheading:15362966-C-Peptide,
pubmed-meshheading:15362966-Diabetes Mellitus, Type 2,
pubmed-meshheading:15362966-Diabetic Retinopathy,
pubmed-meshheading:15362966-Follow-Up Studies,
pubmed-meshheading:15362966-Glycosylation End Products, Advanced,
pubmed-meshheading:15362966-Humans,
pubmed-meshheading:15362966-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:15362966-Lipids,
pubmed-meshheading:15362966-Middle Aged,
pubmed-meshheading:15362966-Prevalence,
pubmed-meshheading:15362966-Prospective Studies,
pubmed-meshheading:15362966-Proteins
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes.
|
|
pubmed:affiliation |
Department of Vascular Diseases, Malmo University Hospital, Malmo, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
